Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 8;5(12):115.
doi: 10.3390/jcm5120115.

Bronchiectasis in the Last Five Years: New Developments

Jun Keng Khoo  1 , Victoria Venning  2 , Conroy Wong  3 , Lata Jayaram  4   5
Affiliations
Review

Bronchiectasis in the Last Five Years: New Developments

Jun Keng Khoo et al. J Clin Med. .

Abstract

Bronchiectasis, a chronic lung disease characterised by cough and purulent sputum, recurrent infections, and airway damage, is associated with considerable morbidity and mortality. To date, treatment options have been limited to physiotherapy to clear sputum and antibiotics to treat acute infections. Over the last decade, there has been significant progress in understanding the epidemiology, pathophysiology, and microbiology of this disorder. Over the last five years, methods of assessing severity have been developed, the role of macrolide antibiotic therapy in reducing exacerbations cemented, and inhaled antibiotic therapies show promise in the treatment of chronic Pseudomonas aeruginosa infection. Novel therapies are currently undergoing Phase 1 and 2 trials. This review aims to address the major developments within the field of bronchiectasis over this time.

Keywords: bronchiectasis; comorbidities; microbiome; severity scores; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Chang A.B., Bell S.C., Torzillo P.J., King P.T., Maguire G.P., Byrnes C.A., Holland A.E., O’Mara P., Grimwood K. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med. J. Aust. 2015;202:21–23. doi: 10.5694/mjac14.00287. - DOI - PubMed
    1. Pasteur M.C., Bilton D., Hill A.T., British Thoracic Society Bronchiectasis non-CF Guideline Group British thoracic society guideline for non-cf bronchiectasis. Thorax. 2010;65(Suppl. 1):i1–i58. doi: 10.1136/thx.2010.136119. - DOI - PubMed
    1. Polverino E., Cacheris W., Spencer C., Operschall E., O’Donnell A. Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis. ERJ. 2012;40:P3983.
    1. Kovesi T. Respiratory disease in canadian first nations and inuit children. Paediatr. Child Health. 2012;17:376–380. - PMC - PubMed
    1. Bibby S., Milne R., Beasley R. Hospital admissions for non-cystic fibrosis bronchiectasis in new zealand. N. Z. Med. J. 2015;128:30–38. - PubMed

LinkOut - more resources